Literature DB >> 14562139

Single step isolation of sildenafil from commercially available Viagra tablets.

S H Francis1, K Raja Sekhar, A B Rouse, K A Grimes, J D Corbin.   

Abstract

Sildenafil, the active ingredient in Viagra, has been purified from commercially available tablets. The purification, using Sephadex G25 chromatography under conditions of low ionic strength, is simple and inexpensive. Sildenafil purified according to this protocol has been characterized with respect to its IC50 for PDE5, its ultraviolet absorption profile, and by collision-induced dissociation fingerprinting, positive ion nanospray, and MALDI mass spectrometry. Tritated sildenafil (6 Ci/mmol) was prepared commercially using the sildenafil purified by this protocol and was verified to retain the potency of unlabeled sildenafil. This protocol and similar procedures will allow investigators to easily isolate sufficient amounts of sildenafil or other PDE5 inhibitors for conducting biochemical and in vitro studies of drug action.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14562139     DOI: 10.1038/sj.ijir.3901040

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  8 in total

1.  Allosteric-site and catalytic-site ligand effects on PDE5 functions are associated with distinct changes in physical form of the enzyme.

Authors:  Jackie D Corbin; Roya Zoraghi; Sharron H Francis
Journal:  Cell Signal       Date:  2009-08-06       Impact factor: 4.315

2.  Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance.

Authors:  Zhi Shi; Amit K Tiwari; Suneet Shukla; Robert W Robey; Satyakam Singh; In-Wha Kim; Susan E Bates; Xingxiang Peng; Ioana Abraham; Suresh V Ambudkar; Tanaji T Talele; Li-Wu Fu; Zhe-Sheng Chen
Journal:  Cancer Res       Date:  2011-03-14       Impact factor: 12.701

3.  Sildenafil reduces insulin-resistance in human endothelial cells.

Authors:  Caterina Mammi; Donatella Pastore; Marco F Lombardo; Francesca Ferrelli; Massimiliano Caprio; Claudia Consoli; Manfredi Tesauro; Lucia Gatta; Massimo Fini; Massimo Federici; Paolo Sbraccia; Giulia Donadel; Alfonso Bellia; Giuseppe M Rosano; Andrea Fabbri; Davide Lauro
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

4.  Interactions between cyclic nucleotide phosphodiesterase 11 catalytic site and substrates or tadalafil and role of a critical Gln-869 hydrogen bond.

Authors:  James L Weeks; Jackie D Corbin; Sharron H Francis
Journal:  J Pharmacol Exp Ther       Date:  2009-07-29       Impact factor: 4.030

5.  Sildenafil accelerates reentrainment of circadian rhythms after advancing light schedules.

Authors:  Patricia V Agostino; Santiago A Plano; Diego A Golombek
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-22       Impact factor: 11.205

6.  Blockade of phosphodiesterase Type 5 enhances rat neurohypophysial excitability and electrically evoked oxytocin release.

Authors:  Zhenjie Zhang; Vitaly Klyachko; Meyer B Jackson
Journal:  J Physiol       Date:  2007-08-09       Impact factor: 5.182

7.  Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions.

Authors:  Lindsay S Wilson; Hisham S Elbatarny; Scott W Crawley; Brian M Bennett; Donald H Maurice
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

8.  cGMP-phosphodiesterase inhibition enhances photic responses and synchronization of the biological circadian clock in rodents.

Authors:  Santiago A Plano; Patricia V Agostino; Horacio O de la Iglesia; Diego A Golombek
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.